ICU Medical, Inc. (ICUI)
182.61
-0.23
(-0.13%)
USD |
NASDAQ |
Aug 24, 16:00
182.61
0.00 (0.00%)
After-Hours: 20:00
ICU Medical EPS Diluted (Quarterly) : 0.7621 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7621 |
| March 31, 2026 | 1.197 |
| December 31, 2025 | -0.6373 |
| September 30, 2025 | -0.1376 |
| June 30, 2025 | 1.430 |
| March 31, 2025 | -0.6307 |
| December 31, 2024 | -0.9729 |
| September 30, 2024 | -1.350 |
| June 30, 2024 | -0.8776 |
| March 31, 2024 | -1.630 |
| December 31, 2023 | -0.7103 |
| September 30, 2023 | 0.297 |
| June 30, 2023 | -0.4126 |
| March 31, 2023 | -0.4086 |
| December 31, 2022 | -0.6477 |
| September 30, 2022 | -0.5524 |
| June 30, 2022 | -0.3128 |
| March 31, 2022 | -1.610 |
| December 31, 2021 | 0.9137 |
| September 30, 2021 | 1.430 |
| June 30, 2021 | 1.308 |
| March 31, 2021 | 1.094 |
| December 31, 2020 | 1.210 |
| September 30, 2020 | 1.159 |
| June 30, 2020 | 0.8792 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7827 |
| December 31, 2019 | 0.9648 |
| September 30, 2019 | 1.236 |
| June 30, 2019 | 1.061 |
| March 31, 2019 | 1.438 |
| December 31, 2018 | -0.359 |
| September 30, 2018 | 0.0101 |
| June 30, 2018 | 1.440 |
| March 31, 2018 | 0.2278 |
| December 31, 2017 | 2.33 |
| September 30, 2017 | 0.01 |
| June 30, 2017 | -1.87 |
| March 31, 2017 | 2.86 |
| December 31, 2016 | 0.54 |
| September 30, 2016 | 1.09 |
| June 30, 2016 | 0.98 |
| March 31, 2016 | 1.08 |
| December 31, 2015 | 0.33 |
| September 30, 2015 | 0.98 |
| June 30, 2015 | 0.83 |
| March 31, 2015 | 0.60 |
| December 31, 2014 | 0.46 |
| September 30, 2014 | 0.42 |
| June 30, 2014 | 0.38 |
| March 31, 2014 | 0.43 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | 0.2432 |
| Becton, Dickinson & Co. | 1.370 |
| Boston Scientific Corp. | 0.615 |
| Glaukos Corp. | -0.3124 |
| Medline, Inc. | 0.0697 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.09M |
| Revenue (Quarterly) | 552.19M |
| Total Expenses (Quarterly) | 533.10M |
| Enterprise Value | 5.561B |
| Gross Profit Margin (Quarterly) | 36.74% |
| Profit Margin (Quarterly) | 3.46% |
| Earnings Yield | 0.65% |
| Operating Earnings Yield | 3.17% |
| Normalized Earnings Yield | 1.752 |